Profund Advisors’s KalVista Pharmaceuticals KALV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$113K	Buy	+10,020	New	+$113K	﹤0.01%	956
2025 Q1	–	Sell	-10,762	Closed	-$91.2K	–	1050
2024 Q4	$91.2K	Buy	+10,762	New	+$91.2K	﹤0.01%	1075